Z3 Capital Partners’s Profound Medical PROF Stock Holding History
Bought
Maintained
Sold
Other funds holding PROF
GA
MI
Z3 Capital Partners's PROF Position: Q3 2026 in Review
Z3 Capital Partners reduced its Profound Medical (PROF) stake by 4.6% in Q3 2026, selling an estimated $257K and leaving 783,141 shares worth $4.54M. The position accounts for 0.94% of the portfolio, ranked #30.
Z3 Capital Partners first reported a position in PROF in Q4 2025 and has held it in 4 quarters since. The position peaked at $6.45M in Q4 2025. 43 funds tracked by Wall St. Rank hold PROF as of Q3 2026.
- Z3 Capital Partners held 783,141 shares of Profound Medical worth $4.54M as of Q3 2026.
- Z3 Capital Partners sold 37,800 Profound Medical shares in Q3 2026, an estimated $257K.
- Profound Medical made up 0.94% of Z3 Capital Partners's portfolio in Q3 2026, its #30 holding.
- Z3 Capital Partners first reported a position in Profound Medical in Q4 2025 and has held it in 4 quarters since.
- Z3 Capital Partners's Profound Medical position peaked at $6.45M in Q4 2025.
- 43 funds tracked by Wall St. Rank held Profound Medical as of Q3 2026.
Based on Z3 Capital Partners's 13F filing for Q3 2026, filed 10 Nov 2026.